William DeVinney

Counsel

Washington, D.C.
T 202.861.1554  |  F 202.861.1783

William DeVinney has a broad litigation practice that includes antitrust, intellectual property, commercial class action, securities, and other complex commercial litigation. He has extensive trial experience, both as a member of trial teams and as first chair in jury and bench trials, arbitrations proceedings, and regulatory hearings. William has also argued cases before several federal and state appellate courts. He also counsels clients on antitrust issues.

Select Experience

  • Member of team representing certified class of dairy farmers located in 14 Southeastern States against Dairy Farmers of America, Dean Foods, and a number of other defendants in an action alleging violations of Sections 1 and 2 of the Sherman Act by unlawfully conspiring to eliminate competition for marketing, sale, and purchase of raw milk in the Southeast United States. Litigation was settled for more than 70 percent of alleged damages.
  • Represented multinational consumer goods company in consumer class action alleging false advertising. Complaint against client dismissed with prejudice.
  • Represented multinational chemical and agricultural biotechnology corporation against Sherman Act Section 2 claim brought by competitor alleging that client had either monopolized or attempted to monopolize alleged market for transgenic corn seed.
More »

Experience

  • Member of team representing certified class of dairy farmers located in 14 Southeastern States against Dairy Farmers of America, Dean Foods, and a number of other defendants in an action alleging violations of Sections 1 and 2 of the Sherman Act by unlawfully conspiring to eliminate competition for marketing, sale, and purchase of raw milk in the Southeast United States. Litigation was settled for more than 70 percent of alleged damages.
  • Represented multinational consumer goods company in consumer class action alleging false advertising. Complaint against client dismissed with prejudice.
  • Represented multinational chemical and agricultural biotechnology corporation against Sherman Act Section 2 claim brought by competitor alleging that client had either monopolized or attempted to monopolize alleged market for transgenic corn seed.
  • Defended multinational chemical and agricultural biotechnology company accused of monopolizing market for transgenic corn seed industry. Motion for class certification by plaintiff rejected by trial court and before Third Circuit on appeal.
  • Represented multinational technology company in private antitrust claim brought by competitor, as well as in investigations brought by the EU, Federal Trade Commission, and state government enforcement agencies.
  • Defended former executive of Bankers Trust Corporation in criminal trial and related SEC administrative proceedings arising from alleged improper accounting treatment of unclaimed funds. After six-week jury trial, client was acquitted of all 36 counts in indictment and favorable settlement was reached with SEC.

Pro Bono

  • Served as lead counsel for three congressmen and a public interest group filing amicus brief in United States Supreme Court.
  • Represented several clients in fair housing cases in antidiscrimination, fair housing, landlord/tenant, and contractual disputes.

Services

Admissions

  • U.S. Supreme Court
  • U.S. Court of Appeals, Federal Circuit
  • U.S. District Court, District of Columbia
  • U.S. District Court, Eastern District of New York
  • U.S. District Court, Southern District of New York
  • District of Columbia
  • New York

Education

  • J.D., William & Mary Law School, 1998
  • B.S., Cornell University, 1991

Blog

In The Blogs

Previous Next
Antitrust Advocate
CFIUS Report Reflects Continued Need to Plan for Government Scrutiny of Cross-border Transactions
March 24, 2015
The Committee on Foreign Investment in the United States (CFIUS) recently reported its 2013 activities, confirming the continuation of its heightened review and investigation of certain foreign direct investments in U.S. businesses. CFIUS...
Read More ->
Antitrust Advocate
FTC’s Appellate Win Reflects Focus on Health Care Consolidation
March 10, 2015
In an important victory for the Federal Trade Commission in the appellate courts, the U.S. Court of Appeals for the Ninth Circuit recently affirmed last year’s decision from the District of Idaho in Saint Alphonsus Medical Center v. St...
Read More ->
Antitrust Advocate
FTC Commissioner Wright Calls for Vote on Section 5 Guidelines
February 27, 2015
FTC Commissioner Joshua Wright, during yesterday’s keynote speech at BakerHostetler’s Section 5 Symposium, announced his plan to call for the FTC Commissioners to vote on three proposed definitions of Section 5’s “unfair methods of...
Read More ->
Antitrust Advocate
Symposium on Section 5 of the Federal Trade Commission Act
February 19, 2015
Companies and institutions may be vulnerable to FTC claims of antitrust or consumer fraud violations without realizing it. Learn how to help prevent such potentially damaging issues through a groundbreaking, BakerHostetler-sponsored...
Read More ->
Antitrust Advocate
To Report or Not to CFIUS, That Is the Question
February 16, 2015
With the complexities inherent in many cross-border transactions – from cultural differences to the growing number of competition authorities demanding paperwork – the last thing one may want to think about is whether to submit a voluntary...
Read More ->